Azurity Pharmaceuticals, Inc. et al v. Accord Healthcare, Inc.
| Azurity Pharmaceuticals, Inc. and EMP Levo US B.V. |
| Accord Healthcare, Inc. |
| 1:2023cv00373 |
| March 31, 2023 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 24, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 WAIVER OF SERVICE returned executed by EMP Levo US B.V., Azurity Pharmaceuticals, Inc.: For Accord Healthcare, Inc. waiver sent on 4/21/2023, answer due 6/20/2023. (Liston, Ian) |
| Pro Hac Vice Attorney Wendy L. Devine, Kristina M. Hanson, and Jody Karol for Azurity Pharmaceuticals, Inc. and EMP Levo US B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Wendy L. Devine, Kristina M. Hanson, and Jody Karol - filed by Azurity Pharmaceuticals, Inc., EMP Levo US B.V.. (Attachments: #1 Certification of Wendy L. Devine, #2 Certification of Kristina M. Hanson, #3 Certification of Jody Karol)(Liston, Ian) |
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Wendy L. Devine, Kristina M. Hanson, and Jody Karol, filed by EMP Levo US B.V., Azurity Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 4/12/2023. (kmd)
|
| Filing 8 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 7 Summons Issued as to Accord Healthcare, Inc. on 3/31/2023. (vfm) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent EMP Levo Holding B.V. for EMP Levo US B.V. filed by Azurity Pharmaceuticals, Inc., EMP Levo US B.V. (vfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma Intermediate Holdings, Inc. for Azurity Pharmaceuticals, Inc. filed by Azurity Pharmaceuticals, Inc., EMP Levo US B.V. (vfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,050,307. (vfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/22/2023. Date of Expiration of Patent: 08/06/2031.Thirty Month Stay Deadline: 9/29/2025. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Accord Healthcare, Inc. ( Filing fee $ 402, receipt number CDEDC-4103289.) - filed by EMP Levo US B.V., Azurity Pharmaceuticals, Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet) (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
